# MaaT Pharma

> Microbiome-based therapeutics development

Business model and tags: B2B, Publicly traded, Pharma & life sciences, Has in-house R&D

## About MaaT Pharma

MaaT Pharma specializes in restoring patient-microbiome symbiosis to improve outcomes in blood cancers and graft-versus-host disease through innovative therapeutics

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 51–250 employees
- **Headquarters**: Lyon, Auvergne-Rhône-Alpes, France
- **Founded**: 2014
- **Revenue**: €4.5M (FY2025, publicly reported)
- **Website**: [maatpharma.com](https://www.maatpharma.com/)
- **LinkedIn**: [linkedin.com/company/maat-pharma](https://www.linkedin.com/company/maat-pharma)

## MaaT Pharma at a glance

MaaT Pharma is a B2B company in the Biotechnology Research industry, headquartered in Lyon, Auvergne-Rhône-Alpes, France.

MaaT Pharma was founded in 2014.

MaaT Pharma has 51–250 employees.

MaaT Pharma's revenue is €4.5M (FY2025, publicly reported).

## Frequently asked questions about MaaT Pharma

### What is MaaT Pharma's revenue?

MaaT Pharma's revenue is €4.5M (FY2025, publicly reported).

### How many employees does MaaT Pharma have?

MaaT Pharma has 51–250 employees.

### Where is MaaT Pharma headquartered?

MaaT Pharma is headquartered in Lyon, Auvergne-Rhône-Alpes, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/maat-pharma
